Revenue Recognition - Schedule of net revenue from collaboration arrangement (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Revenue Recognition and Collaboration Arrangements | ||
| Total net royalty revenue | $ 88,632 | $ 77,499 |
| Royalty Revenue | ||
| Revenue Recognition and Collaboration Arrangements | ||
| Total net royalty revenue | 57,807 | 58,415 |
| GSK | ||
| Revenue Recognition and Collaboration Arrangements | ||
| Total net royalty revenue | 57,807 | 58,415 |
| GSK | Royalty Revenue | ||
| Revenue Recognition and Collaboration Arrangements | ||
| Total royalties | 61,263 | 61,871 |
| Less: amortization of capitalized fees paid | (3,456) | (3,456) |
| GSK | RELVAR/BREO | ||
| Revenue Recognition and Collaboration Arrangements | ||
| Total royalties | 50,890 | 52,138 |
| GSK | ANORO | ||
| Revenue Recognition and Collaboration Arrangements | ||
| Total royalties | $ 10,373 | $ 9,733 |
| X | ||||||||||
- Definition Gross Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer before amortization of capitalized fees. No definition available.
|
| X | ||||||||||
- Definition Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|